Oral medicines for Covid-19 are expected to be in short supply in Australia for the first few months after the drugs regulator gave them the green light. Earlier this month, the Therapeutic Goods Administration granted provisional approval to Pfizer’s Paxlovid ...

From 1 July, the NIP Schedule at 12 months of age has changed 1-4 To ensure the NIP Schedule is aligned with changes in disease patterns, an update has been made to the recommendations on the use of pneumococcal and meningococcal ...